These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 4678404)

  • 21. The effect of N-gamma-phenylpropyl-N-benzyloxy acetamide (W-1372) on experimental atherosclerosis and hypercholesteremia.
    Berger FM; Douglas JF; Ludwig BJ; Margolin S
    J Pharmacol Exp Ther; 1969 Dec; 170(2):371-81. PubMed ID: 4982312
    [No Abstract]   [Full Text] [Related]  

  • 22. Epigallocatechin gallate improves serum lipid profile and erythrocyte and cardiac tissue antioxidant parameters in Wistar rats fed an atherogenic diet.
    Ramesh E; Elanchezhian R; Sakthivel M; Jayakumar T; Senthil Kumar RS; Geraldine P; Thomas PA
    Fundam Clin Pharmacol; 2008 Jun; 22(3):275-84. PubMed ID: 18485145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Basic treatment of coronary atherosclerosis].
    Barrillon A; Binet JP; de Gennes JL; Hazan E; Lenègre J
    Presse Med (1893); 1969 Jun; 77(28):1013-6. PubMed ID: 5795147
    [No Abstract]   [Full Text] [Related]  

  • 24. Nicotinic acid: new/old drug. Immediate or sustained release: too risky for a drug with no proven benefit.
    Prescrire Int; 2006 Dec; 15(86):213-6. PubMed ID: 17165243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of a combination of vasoactive substances on the metabolism and the rheoencephalogram].
    Hammerl H; Kränzl C; Nebosis G; Pichler O; Studlar M
    Wien Med Wochenschr; 1973 Sep; 123(37):533-8. PubMed ID: 4152665
    [No Abstract]   [Full Text] [Related]  

  • 26. Studies on new nicotinic acid ester derivatives. 6. Serum cholesterol level lowering effect of 2,2,6,6-tetrakis(nicotinoyloxymethyl) cyclohexanol (K-31).
    Aso Y; Abe Y; Higo K; Naruke T; Irikura T
    J Atheroscler Res; 1969; 10(3):391-401. PubMed ID: 5364087
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of BM 15.766 on serum lipids in rats.
    Pill J; Schmidt FH; Stegmeier K; Witte EC
    Horm Metab Res; 1985 Oct; 17(10):543-4. PubMed ID: 3840766
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparison of the antilipemic effect of nicotinic acid (NA) and 3-methylpyrazole-5-carboxylic acid (MPC) in rats.
    Tamási G; Borsy J; Patthy A
    Biochem Pharmacol; 1968 Sep; 17(9):1789-94. PubMed ID: 5688267
    [No Abstract]   [Full Text] [Related]  

  • 29. Pool size and turnover of bile acids in six hypercholesteremic patients with and without administration of nicotinic acid.
    Wollenweber J; Kottke BA; Owen CA
    J Lab Clin Med; 1967 Apr; 69(4):584-93. PubMed ID: 6020697
    [No Abstract]   [Full Text] [Related]  

  • 30. Hypolipemic activity of 1,2-alpha-oxido-4,6-androstadiene-3,17 dione (Compound 51).
    Linèt O
    Arzneimittelforschung; 1969 Nov; 19(11):1899-900. PubMed ID: 5395665
    [No Abstract]   [Full Text] [Related]  

  • 31. [Ophthalmodynamometric and tonographic analysis of the influence of a vasodilator agent on intracranial blood circulation and intraocular pressure].
    Makabe R
    Klin Monbl Augenheilkd; 1971 Feb; 158(2):309. PubMed ID: 5555614
    [No Abstract]   [Full Text] [Related]  

  • 32. Absorption and excretion of radioactive pentaerythritoltetranicotinate, mesoinositolhexanicotinate and nicotinic acid after oral administration to cat.
    Brattsand R; Harthon L
    Arzneimittelforschung; 1971 Sep; 21(9):1335-8. PubMed ID: 5171788
    [No Abstract]   [Full Text] [Related]  

  • 33. [To the mechanism of hypotensive effect of ethyl ether of nicotinic acid (Nicethane)].
    Sidoruk GIa
    Farmakol Toksikol; 1966; 29(2):135-6. PubMed ID: 6000335
    [No Abstract]   [Full Text] [Related]  

  • 34. -Pyridylcarbinol in experimental hypercholesterinemia of the rabbit. Study of lipidic fractions and of the mechanisms of hemostasis.
    Giarola P; Egge H; Gibelli A; Müller J
    Farmaco Sci; 1972 Nov; 27(11):1018-23. PubMed ID: 4647185
    [No Abstract]   [Full Text] [Related]  

  • 35. Newer hypolipidemic agents.
    Kritchevsky D
    Fed Proc; 1971; 30(3):835-40. PubMed ID: 4996475
    [No Abstract]   [Full Text] [Related]  

  • 36. [Role of magnesium, potassium, antikaliuretic agents and hypocholesteremic agents in cardiac lesion development in rats fed a thrombogenic diet and Na 2 HPO 4 ].
    Savoie LL
    Pathol Biol (Paris); 1972 Oct; 20(19):751-6. PubMed ID: 4343433
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical pharmacology and pharmacokinetics of nicotinic acid.
    Weiner M
    Drug Metab Rev; 1979; 9(1):99-106. PubMed ID: 376259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Nicotinic acid and fibrinolysis in humans. I. Regional fibrinolysis (cerebral, of the upper extremity and of the lower extremity) caused by "arterial" administration of nicotinic acid].
    Tesi M
    Riv Crit Clin Med; 1967 Dec; 67(6):465-83. PubMed ID: 5603691
    [No Abstract]   [Full Text] [Related]  

  • 39. Ascorbic acid and experimental atherosclerosis.
    Datey KK; Dalvi CP; Mehta NJ; Purandare NM
    J Assoc Physicians India; 1968 Sep; 16(9):567-70. PubMed ID: 5711915
    [No Abstract]   [Full Text] [Related]  

  • 40. Absorption in rats, dogs, pigs, and humans of nicotinic acid after oral administration of phosphatidyl inositol pentanicotinate hydrochloride (PIN).
    Hertle H; Kiese M; Renner G
    Arzneimittelforschung; 1979; 29(1):114-6. PubMed ID: 582105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.